30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mottola Frank

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Mottola Frank's trades of Supernus Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-10 2026-03-09 S Sale
16,452 -43.1%
113.44
US$1,805,867
16,452 -43.1% 113.44 US$1,805,867
2026-03-09 2026-03-09 PrS Proposed sale
61,975
129.44
US$1,411,436
61,975 129.44 US$1,411,436
2025-12-22 2025-12-19 PlS Planned sale
27,241 +36.7%
82.73
US$676,405
27,241 +36.7% 82.73 US$676,405
2025-12-22 2025-12-19 PlS Planned sale
5,000 -24.4%
50.22
US$251,100
5,000 -24.4% 50.22 US$251,100
2025-12-19 2025-12-19 PrS Proposed sale
20,000
49.28
US$985,600
20,000 49.28 US$985,600
2025-09-15 2025-09-12 S Sale
5,000 -24.4%
45.87
US$229,350
5,000 -24.4% 45.87 US$229,350
2025-09-12 2025-09-12 PrS Proposed sale
5,000
45.87
US$229,338
5,000 45.87 US$229,338
2025-08-27 2025-08-25 S Sale
14,000 -47.5%
44.51
US$623,140
14,000 -47.5% 44.51 US$623,140
2025-08-25 2025-08-25 PrS Proposed sale
14,000
44.51
US$623,070
14,000 44.51 US$623,070
2024-11-08 2024-11-07 S Sale
15,000 -64.7%
36.98
US$554,700
15,000 -64.7% 36.98 US$554,700
2024-11-07 2024-11-07 PrS Proposed sale
15,000
36.98
US$554,692
15,000 36.98 US$554,692
2023-11-16 2023-11-14 S Sale
1,110 -16.3%
28.13
US$31,224
1,110 -16.3% 28.13 US$31,224
2023-11-14 2023-11-14 PrS Proposed sale
1,110
28.13
US$31,222
1,110 28.13 US$31,222
2023-03-16 2023-03-14 S Sale
4,780 -50.2%
35.99
US$172,023
4,780 -50.2% 35.99 US$172,023